Autolus Therapeutics: Q1 Earnings Insights

Autolus Therapeutics AUTL reported its Q1 earnings results on Thursday, May 4, 2023 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Autolus Therapeutics beat estimated earnings by 14.81%, reporting an EPS of $-0.23 versus an estimate of $-0.27.

Revenue was up $1.13 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.04 which was followed by a 6.25% increase in the share price the next day.

To track all earnings releases for Autolus Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.